Overall clinical success rates at TOC were @ % ( @ of @ patients ) in the moxifloxacin and @ % ( @ of @ patients ) in the comparator treatment groups ( PP population , point estimate for the difference in success rates : -@ % ; @ % CI -@ % , @ % ) , respectively .